Loading…
Loading…
THCBF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for THCBF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for THCBF and 80,000+ other tickers.
See exactly how THCBF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for THCBF and 80,000+ other tickers.
THC Biomed Intl Ltd. is a Canadian enterprise engaged in the production and sale of cannabis products for both medical and recreational consumers. Its offerings encompass a range of cannabis-infused edibles and drinks, such as beverage shots, gummies, and biscuits marketed under the THC KISS label, in addition to standalone pure cannabis sticks. This company was established in 2012 and operates from its headquarters in Kelowna, Canada.
No recent news available.